001     165146
005     20230915090607.0
024 7 _ |a pmc:PMC9482346
|2 pmc
024 7 _ |a 10.1242/jcs.260227
|2 doi
024 7 _ |a pmid:35950506
|2 pmid
024 7 _ |a 0021-9533
|2 ISSN
024 7 _ |a 0370-2952
|2 ISSN
024 7 _ |a 1477-9137
|2 ISSN
037 _ _ |a DZNE-2022-01451
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Park, Jae-Sook
|0 0000-0002-9045-1280
|b 0
245 _ _ |a Interaction between VPS13A and the XK scramblase is important for VPS13A function in humans.
260 _ _ |a Cambridge
|c 2022
|b Company of Biologists Limited
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1663333634_24001
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a VPS13 family proteins form conduits between the membranes of different organelles through which lipids are transferred. In humans, there are four VPS13 paralogs, and mutations in the genes encoding each of them are associated with different inherited disorders. VPS13 proteins contain multiple conserved domains. The Vps13 adaptor-binding (VAB) domain binds to adaptor proteins that recruit VPS13 to specific membrane contact sites. This work demonstrates the importance of a different domain in VPS13A function. The pleckstrin homology (PH) domain at the C-terminal region of VPS13A is required to form a complex with the XK scramblase and for the co-localization of VPS13A with XK within the cell. Alphafold modeling was used to predict an interaction surface between VPS13A and XK. Mutations in this region disrupt both complex formation and co-localization of the two proteins. Mutant VPS13A alleles found in patients with VPS13A disease truncate the PH domain. The phenotypic similarities between VPS13A disease and McLeod syndrome caused by mutations in VPS13A and XK, respectively, argue that loss of the VPS13A-XK complex is the basis of both diseases.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Lipid transport
|2 Other
650 _ 7 |a Neuro-acanthocytosis syndromes
|2 Other
650 _ 7 |a Neurodegeneration
|2 Other
650 _ 7 |a PH domain
|2 Other
650 _ 7 |a VPS13A
|2 Other
650 _ 7 |a XK
|2 Other
650 _ 7 |a VPS13A protein, human
|2 NLM Chemicals
650 _ 7 |a Vesicular Transport Proteins
|2 NLM Chemicals
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Mitochondrial Membranes: metabolism
|2 MeSH
650 _ 2 |a Mutation: genetics
|2 MeSH
650 _ 2 |a Neuroacanthocytosis: complications
|2 MeSH
650 _ 2 |a Neuroacanthocytosis: genetics
|2 MeSH
650 _ 2 |a Neuroacanthocytosis: metabolism
|2 MeSH
650 _ 2 |a Vesicular Transport Proteins: genetics
|2 MeSH
650 _ 2 |a Vesicular Transport Proteins: metabolism
|2 MeSH
700 1 _ |a Hu, Yiying
|0 P:(DE-2719)9000587
|b 1
|u dzne
700 1 _ |a Hollingsworth, Nancy M
|b 2
700 1 _ |a Miltenberger-Miltenyi, Gabriel
|b 3
700 1 _ |a Neiman, Aaron M
|0 0000-0002-6600-6996
|b 4
773 _ _ |a 10.1242/jcs.260227
|g Vol. 135, no. 17, p. jcs260227
|0 PERI:(DE-600)1483099-1
|n 17
|p jcs260227
|t Journal of cell science
|v 135
|y 2022
|x 0021-9533
909 C O |o oai:pub.dzne.de:165146
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)9000587
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-31
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-31
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-31
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J CELL SCI : 2021
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-11
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-11
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J CELL SCI : 2021
|d 2022-11-11
920 1 _ |0 I:(DE-2719)1140002
|k Zebrafish Models ; AG Schmid München
|l Zebrafish Models
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1140002
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21